JPRN-jRCTs031180338
Completed
Phase 2
The prospective study to evaluate the efficacy of the combination therapy of inhaled budesonide/formoterol fumarate, clarithromycin, and montelukast in AFO after allogeneic SCT - Chiba AFO-01 study
Sakaida Emiko0 sites85 target enrollmentMarch 18, 2019
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Air flow obstruction after allogeneic SCT
- Sponsor
- Sakaida Emiko
- Enrollment
- 85
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. The patient who receives the 1st allogeneic stem cell transplantation
- •2\. The patient who can examine the pulmonary function tests.
- •3\. PS (ECOG), 0\-2
- •4\. The patient who has no exceptionable organ problems
- •1\) serum ALT/AST concentrations:150 IU/L and under
- •2\) total bilirubin: 3mg/dL and under
- •3\) CCr:40ml/min or over (by C\-G)
- •4\) arterial blood oxygen saturation or SpO2 in room air:94% or over
- •5\. Written informed consent
Exclusion Criteria
- •1\. Known history of intolerance or allergy to any triplet component.
- •2\. The patient who has past history of asthma and had attack within one year.
- •3\. The patient who has already been treated with the triplet combination.
- •4\. The patient who has active infection
- •5\. The patient who has mental disability requiring treatment
- •6\. The patient who has severe thromboembolism, including myocardial infarction, cerebral infarction, and cardiovascular complications.
- •7\. The patient who has uncontrollable diabetes mellitus and metabolic disease
- •8\. The patient who has other malignancy requiring anticancer treatment
- •9\. Pregnancy or nursing.
- •10\. At the time of enrollment as judged by the enrolling investigator would interfere
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The prospective study to evaluate the efficacy of the combination therapy of inhaled budesonide/formoterol fumarate, clarithromycin, and montelukast in AFO after allogeneic SCTAir flow obstruction after allogeneic SCTJPRN-UMIN000022048Department of Hematology, Chiba University Hospital85
Completed
Phase 1
A prospective study to investigate the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for pseudomyxoma peritoneipseudomyxoma peritoneiJPRN-UMIN000011384ational Center for Global Health and Medicine75
Active, not recruiting
Phase 1
A prospective study to assess the effectiveness of lignocaine versus normal saline in the reduction of pain associated with dressing removal in finger tip injuriesFinger tip injuriesEUCTR2005-005591-32-GBDerby Hospitals NHS Foundation Trust20
Completed
Not Applicable
A prospective study to assess the effectiveness of lignocaine versus normal saline in the reduction of pain associated with dressing removal in fingertip injuriesISRCTN59113767Record Provided by the NHSTCT Register - 2007 Update - Department of Health98
Recruiting
Not Applicable
A prospective study for evaluation of efficacy of a 12mm diameter polytetrafluoroethylene partial covered stent in malignant extrahepatic biliary obstructioKCT0005989Asan Medical Center161